These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2217675)

  • 21. The effects of ursodeoxycholic acid alone and ursodeoxycholic acid plus low-dose acetylsalicylic acid on radiolucent gallstones.
    Tuncer I; Harman M; Mercan R; Oztürk M; Arslan I; Meral C; Türkdoğan MK
    Turk J Gastroenterol; 2003 Jun; 14(2):91-6. PubMed ID: 14614633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
    Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
    Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
    Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
    Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
    Polli EE; Bianchi PA; Conte D; Sironi L
    Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallstone dissolution with oral bile acid therapy. Importance of pretreatment CT scanning and reasons for nonresponse.
    Pereira SP; Veysey MJ; Kennedy C; Hussaini SH; Murphy GM; Dowling RH
    Dig Dis Sci; 1997 Aug; 42(8):1775-82. PubMed ID: 9286247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution.
    Festi D; Frabboni R; Bazzoli F; Sangermano A; Ronchi M; Rossi L; Parini P; Orsini M; Primerano AM; Mazzella G
    Gastroenterology; 1990 Dec; 99(6):1779-85. PubMed ID: 2227291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is recurrence inevitable after gallstone dissolution by bile-acid treatment?
    Ruppin DC; Dowling RH
    Lancet; 1982 Jan; 1(8265):181-5. PubMed ID: 6119557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective, multicenter study on value of computerized tomography (CT) in gallstone disease in predicting response to bile acid therapy.
    Petroni ML; Jazrawi RP; Grundy A; Lanzini A; Pigozzi MG; Biasio A; Heaton KW; Virjee J; Northfield TC
    Dig Dis Sci; 1995 Sep; 40(9):1956-62. PubMed ID: 7555450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissolution of gallstones--when and how?
    Tangedahl T
    Surg Clin North Am; 1979 Oct; 59(5):797-809. PubMed ID: 390740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical studies on dissolution of gallstones using ursodeoxycholic acid.
    Okumura M; Tanikawa K; Chúman Y; Kóji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T
    Gastroenterol Jpn; 1977; 12(6):469-75. PubMed ID: 608570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin added to ursodeoxycholic acid does not enhance disappearance of gallstone fragments after shock wave therapy.
    Sackmann M; Koelbl R; Pauletzki J; Cremer P; Klueppelberg UG; von Ritter C; Sauter G; Holl J; Seidel D; Paumgartner G
    Z Gastroenterol; 1995 Oct; 33(10):585-9. PubMed ID: 7502550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of cholesterol gallstone dissolution by glycocheno-, glyco-ursodeoxycholic acid, and mixtures of both in vitro.
    Raedsch R; Stiehl A; Götz R; Walker S; Kommerell B
    Z Gastroenterol; 1981 Apr; 19(4):159-63. PubMed ID: 7234028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gallstone recurrence after successful dissolution therapy.
    Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
    Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
    Iser JH; Dowling H; Mok HY; Bell GD
    N Engl J Med; 1975 Aug; 293(8):378-83. PubMed ID: 1152936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Computed X-ray tomography in predicting the efficacy of oral cholelithiasis with bile acids].
    Fu XB
    Zhonghua Yi Xue Za Zhi; 1993 Feb; 73(2):81-4, 126. PubMed ID: 8391902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial.
    Hyun JJ; Lee HS; Kim CD; Dong SH; Lee SO; Ryu JK; Lee DH; Jeong S; Kim TN; Lee J; Koh DH; Park ET; Lee IS; Yoo BM; Kim JH
    Gut Liver; 2015 Jul; 9(4):547-55. PubMed ID: 26087862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computed tomography in predicting the efficacy of oral cholelitholysis with bile acids.
    Fu XB; Liu JY; Liu GN; Shao XM; Zhou XS
    Chin Med J (Engl); 1993 Oct; 106(10):734-8. PubMed ID: 8033604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.